September 16, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Joshua Gorsky
|
Re: |
BioCardia, Inc. Registration Statement on Form S-1 File No. 333-290283 |
Acceleration Request
|
Requested Date: |
September 17, 2025 |
|
|
Requested Time: |
4:30 p.m. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. hereby requests that its Registration Statement on Form S-1 (File No. 333-290283) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as we or our counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin D. March at (512) 338-5410.
|
|
Sincerely,
BIOCARDIA, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ David McClung |
|
|
|
|
David McClung Chief Financial Officer |
|
|
cc: |
Peter Altman, Ph.D., BioCardia, Inc. Austin D. March, Wilson Sonsini Goodrich & Rosati |